| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | -65.4% |
| R&D Expense | $17.7M | +53.3% |
| SG&A Expense | $65.0M | -38.1% |
| Operating Income | -$81.7M | +37.3% |
| Interest Expense | $7.3M | -13.3% |
| Income Tax | $0 | — |
| Net Income | -$44.8M | +68.6% |
| EPS (Basic) | -$29.48 | -1246.1% |
| EPS (Diluted) | -$29.48 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.5M | -23.5% |
| Accounts Receivable | $195K | -98.7% |
| Inventory | $8.6M | +0.0% |
| Current Assets | $85.9M | -30.9% |
| Total Assets | $86.8M | -37.7% |
| Current Liabilities | $25.7M | -31.4% |
| Long-term Debt | $43.3M | -45.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.9M | +27.1% |
| Investing Cash Flow | $62.7M | -11.4% |
| Financing Cash Flow | -$7.9M | -118.7% |
| -1246.1% |
| Total Liabilities |
| $67.8M |
| -44.7% |
| Stockholders' Equity | $19.0M | +12.9% |